A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer. - Holloway RW; Temkin SM; Gordon SW; Gupta S; Jada SR; Ahmad S; McGuire WP (Current oncology (Toronto, Ont.), 2025)